Publication | Closed Access

Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Hematological MalignancyMedicineAcute Myeloid LeukemiaMyelodysplastic SyndromesHematologyPathologyPoor ResponseOncologyCancer ResearchMyeloid Neoplasia